CME vs JPM
Based on Invest's signal, JPMorgan Chase & Co. (JPM) currently has the stronger Buy/Hold/Sell rating of the two — a buy versus hold for CME.
| Metric | CME | JPM |
|---|---|---|
| Price | $255.31 | $353.21 |
| Day change | +0.4% | +0.9% |
| Market cap | $92.2B | $938.9B |
| P/E ratio | 21.7 | 16.9 |
| 1-year return | -7.7% | +19.0% |
| Invest signal | Hold | Buy |
Higher market cap, higher 1-year return, lower P/E, and a stronger signal are highlighted. Data is for learning, not financial advice.
Can't decide? Trade both — risk-free.
Start with €1,000,000 in virtual cash and practice buying CME and JPM at live prices.
CME vs JPM: FAQ
Is CME or JPM the better stock to buy?
Based on Invest's signal, JPMorgan Chase & Co. (JPM) currently has the stronger Buy/Hold/Sell rating of the two — a buy versus hold for CME. Remember that Invest's signal is a data-driven snapshot for learning, not financial advice — the best way to understand the difference is to add both to a watchlist and practice trading them with virtual cash.
Which is bigger, CME or JPM?
JPMorgan Chase & Co. is the larger company by market capitalisation ($938.9B vs $92.2B).
Can I practice trading CME and JPM for free?
Yes. Invest is a free stock market simulator — you start with €1,000,000 in virtual cash and can buy and sell both CME and JPM at live market prices, with no real money and no risk. It runs in your browser and as a free iOS app.
